Growth Metrics

Invivyd (IVVD) Receivables (2023 - 2025)

Invivyd posted quarterly Receivables of $14.6 million for Q4 2025, up 30.5% year-on-year from $11.2 million in Q4 2024, and up 43.83% on a QoQ basis from $10.1 million in Q3 2025.

Invivyd (IVVD) has 3 years of Receivables data on file, last reported at $14.6 million in Q4 2025.

  • For the quarter ending Q4 2025, Receivables rose 30.5% year-over-year to $14.6 million; the trailing twelve-month figure through Dec 2025 stood at $14.6 million (up 30.5% YoY), and the FY2025 full-year result was $14.6 million, up 30.5% from the prior year.
  • Receivables for Q4 2025 stood at $14.6 million, up from $10.1 million in the prior quarter.
  • Across five years, Receivables topped out at $14.6 million in Q4 2025 and bottomed at $933000.0 in Q4 2023.
  • The 3-year median for Receivables is $8.8 million (2025), against an average of $8.3 million.
  • The widest annual swing landed in 2024, when Receivables jumped 1097.11%; it then increased 17.65% in 2025.
  • A 3-year view of Receivables shows it stood at $933000.0 in 2023, then surged by 1097.11% to $11.2 million in 2024, then jumped by 30.5% to $14.6 million in 2025.
  • The last three Receivables figures came in at $14.6 million (Q4 2025), $10.1 million (Q3 2025), and $8.8 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Receivables (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 13.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - 4.15 Mn
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 2.00 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 5.73 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 883.96 Mn
10 Invivyd 208.38 Mn -18.31 Mn - 14.58 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 14.58 Mn
Sep 30, 2025 10.13 Mn
Jun 30, 2025 8.81 Mn
Mar 31, 2025 8.75 Mn
Dec 31, 2024 11.17 Mn
Sep 30, 2024 8.61 Mn
Jun 30, 2024 3.54 Mn
Dec 31, 2023 933,000.00